Callan Family Office’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
VPM
RP
VCM
Callan Family Office's ACLS Position: Q1 2026 in Review
Callan Family Office increased its Axcelis (ACLS) stake by 1% in Q1 2026, buying an estimated $2.3K and bringing the position to 2,548 shares worth $237K. The position accounts for 0.01% of the portfolio, ranked #1002.
Callan Family Office first reported a position in ACLS in Q4 2025 and has held it in 2 quarters since. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.
- Callan Family Office held 2,548 shares of Axcelis worth $237K as of Q1 2026.
- Callan Family Office bought 26 Axcelis shares in Q1 2026, an estimated $2.3K.
- Axcelis made up 0.01% of Callan Family Office's portfolio in Q1 2026, its #1002 holding.
- Callan Family Office first reported a position in Axcelis in Q4 2025 and has held it in 2 quarters since.
- 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.
Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.